セッション詳細
International Session ②
2026年11月21日(土) 16:40 〜 17:40
第5会場
Chair: Toshiya Katsura（College of Pharmaceutical Sciences, Ritsumeikan University), Takanori Taogoshi（Department of Pharmacy, Hiroshima University Hospital)
[IO2-1]Pharmacokinetic interaction between nirmatrelvir/ritonavir and nifedipine: A case report
Tomoki Takase1,2, Hirokazu Kuroda3, Keizo Fukushima1, Toshihiko Oda2, Saki Masumoto2, Takanobu Nadai1, Takumi Hotta1, Shoji Fukushima1, Manabu Kume2, Tohru Hashida1,2, Nobuyuki Muroi2 (1.Faculty of Pharmaceutical Science, Kobe Gakuin University, 2.Department of Pharmacy, Kobe City Medical Center General Hospital, 3.General Medicine, Fujita Health University Okazaki Medical Center, 4.Present address: Division of Translational and Clinical Pharmacology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA)
[IO2-3]Association of maternal diabetes and asthma with childhood asthma using real-world data
Airi Ishikawa1, Laila Aboulatta2, Sherif Eltonsy2,3, Kenji Momo4 (1.Department of Pharmacy, Showa Medical University Fujigaoka Hospital, Japan, 2.College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Canada, 3.The Children's Hospital Research Institute of Manitoba, Manitoba, Canada, 4.Division of Clinical Research, Department of Hospital Pharmaceutics, School of Pharmacy, Showa Medical University, Japan)
[IO2-4]Pharmacometric evaluation of maribavir exposure in liver and lung transplant recipients: A case series
Keisuke Umemura1, Ayami Kishimoto1,2, Shunsaku Nakagawa1, Yoshiki Katada1,3, Taiga Osawa1, Miho Takemura1, Keiko Ikuta1, Yurie Katsube1, Natsuki Imayoshi1, Yuki Shigetsura1, Daiki Hira1,4, Miki Nagao3,5, Tomohiro Terada1 (1.Department of Clinical Pharmacology and Therapeutics, Kyoto University Hospital., 2.Faculty of Pharmaceutical Sciences, Kyoto University., 3.Department of Infection Control and Prevention, Kyoto University Hospital., 4.Graduate School of Pharmaceutical Sciences, Kyoto University., 5.Department of Clinical Laboratory Medicine, Graduate School of Medicine, Kyoto University.)
[IO2-5]Pregnancy outcomes after first-trimester exposure to orexin receptor antagonists and ramelteon: Findings based on data from the teratology information institutes in Japan.
Yoriko Miura1,3, Naho Yakuwa2, Mikako Goto2, Miki Akabane1, Masayuki Ishikawa3,4, Masashi Uchida3,4, Shingo Yamazaki3,4, Itsuko Ishii3,4, Koushi Yamaguchi2 (1.Department of Pharmacy, National Center for Child Health and Development, Tokyo, Japan., 2.Japan Drug Information Institute in Pregnancy, Integrated Center for Women's Health, National Center for Child Health and Development, Tokyo, Japan., 3.Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan., 4.Division of Pharmacy, Chiba University Hospital, Chiba, Japan.)